American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns 
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
U.S. Stock Futures Slip as Markets Brace for Big Tech Earnings and Key Data 
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 
U.S. Stock Futures Rise as Investors Eye Big Tech Earnings and AI Momentum 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
Nvidia Confirms Major OpenAI Investment Amid AI Funding Race 
S&P 500 Rises as AI Stocks and Small Caps Rally on Strong Earnings Outlook 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
The World Bank lowered its China growth forecast for the year from 4.3 percent predicted in June to 2.7 percent due to the impact of the pandemic and property sector weaknesses on its economy.
The institution also slashed its forecast for next year from 8.1 percent down to 4.3 percent.
Many analysts believe that China's GDP growth target of around 5.5 percent for the year is now unattainable.
According to the World Bank, outbreaks and growth slowdowns in China have been followed by uneven recoveries.
Disruption to businesses has continued in China as cases surge and some restrictions remain in place.
Health officials have acknowledged that since bulk testing criteria were removed, official data no longer accurately reflect domestic infections.
The IMF forewarned last week that it will likely also reduce its predictions for China, blaming a sustained rise in cases.
The fund revised its growth forecast for China in October, lowering it to 3.2 percent this year, the lowest level in decades from the 4.4 percent it expected the previous year.
According to IMF chief Kristalina Georgieva, they are very likely to downgrade the growth projections for China, both for 2022 and 2023,
As China moves forward with the reopening, experts worry that it is ill-prepared to handle the next wave of diseases since millions of susceptible elderly people have not yet had all of the recommended vaccinations.
